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This article contains original data, ﬁgures and methods used in the
characterization of the liposomal carrier ‘DDC642’ for topical appli-
cations, described in “An elastic liposomal formulation for RNAi-based
topical treatment of skin disorders: proof-of-concept in the treatment of
psoriasis” (Desmet et al., 2016) [1]. Several elastic liposomal formula-
tions have been evaluated for their ability to encapsulate and deliver
RNA interference (RNAi) molecules to cultured primary skin cells. The
efﬁciency and effectiveness of these liposomes were compared to that
of our previously characterized liposomes, the ‘SECosomes’ (SEC)
(Geusens et al., 2010) [2]. After selection of a potential superior carrier,
based on encapsulation and transfection efﬁciency data (Desmet et al.,
2016) [1], the selected DDC642 liposomes were characterized more
in-depth. Herein, a detailed characterization of the DDC642 liposome
and RNAi-loaded lipoplexes is given, including the matching protocols.
& 2016 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
/j.ijpharm.2016.01.042
atology, Ghent University, De Pintelaan 185, Vijverpark, B-9000 Ghent,
et).
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ow data were
acquiredGel imaging system (ChemiDoc-It Imager, UVP or ChemiDoc XRSþ , Bio-Rad),
Cryo-electron microscopy (FEI Tecnai 20, FEI or CM120, Philips), Microplate
reader (FLUOstar OPTIMA, BMG Labtech or EnVision Multilabel Plate Reader,
Perkin Elmer), Flow cytometer (BD LSRFortessa, BD Biosciences), Real-time PCR
detection system (MyiQ iCycler, Bio-Rad), Dynamic light scattering system
(Zetasizer Nano series, Malvern).ata format Raw, analyzed.
xperimental
factorsThe RNAi encapsulation efﬁciency has been analyzed for several liposomal for-
mulations. (Psoriasis-induced) keratinocytes and melanocytes were cultured
in vitro prior to transfection with empty liposomes or loaded lipoplexes, to assess
respectively cytotoxicity and transfection efﬁciency. Split thickness skin was
prepared from thawed human skin, obtained from healthy volunteers, to use in
permeation studies.xperimental
featuresThe encapsulation efﬁciency was evaluated using gel electrophoresis. in vitro
transfection efﬁciency was analyzed by means of ﬂow cytometry and Western
blot. Franz diffusion cell permeation study was used to measure the skin pene-
tration capacity. Cryo-TEM, CellTiter-Glo assay and dynamic light scattering was
used to assess the morphology, cytotoxicity and particle size of the (loaded)
liposomes, respectively.ata source
locationGhent, Belgium.ata accessibility Data are included in this article.Value of the data The data can be used as a guideline for other scientists investigating (topical) carrier systems for
RNAi delivery.
 The data provide a more thorough characterization of the DDC642 liposomes, which hold great
potential as topical delivery system.
 The data provided in this article could be helpful to researchers investigating gene therapy
approaches in skin disorders.1. Data
The DDC642 carrier was evaluated for its potential as topical RNAi delivery system by measuring
the encapsulation efﬁciency, transfection efﬁciency and efﬁcacy in vitro. Data is provided on the
cytotoxicity of the empty liposomes and physicochemical and biological stability of the RNAi-loaded
lipoplexes. Morphological data on the DDC642 liposomes and lipoplexes is provided as Cryo-TEM
images.
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Fig. 1. Images of the gel retardation assays using siRNA- and miRNA-containing complexes. For information about the com-
position and physicochemical parameters of the liposomes and corresponding lipoplexes see Table A in Ref. [1].
Fig. 2. Cryo-TEM images of DDC642 liposomes (A) and lipoplexes (B). Scale bar:100 nm.
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2.1. Materials and reagents
Cy3TM Dye-labeled anti-miR negative control #1 and Cy3TM Dye-labeled pre-miR negative control
#1 were purchased from Life Technologies (Ghent, Belgium). For additional product description,
procedures regarding the liposome and complex formation, cell culture and in vitro transfection, we
refer to the article of Desmet et al. [1].
2.2. Encapsulation efﬁciency by gel retardation assay
A 1.5% agarose gel containing 10% SYBR Safe (Life Technologies, Ghent, Belgium) was used to detect
free, unbound RNAi molecules after complexation. After loading of the lipoplexes (LPX), electro-
phoresis was performed at 120 V during 45 min. Visualization was obtained by UV transillumination
and gel photography using ChemiDoc XRSþ and Image Lab software (Bio-Rad, Eke, Belgium). Incu-
bation of the LPXs with dextran sulfate (DS; Sigma-Aldrich, Bornem, Belgium) at anion charge excess
(10 and 40 DS/RNAi (w/w)) for 30 min provided data on the amount of surface-bound RNA molecules
Table 1
Transfection efﬁciency of the liposomes in cultured primary skin cells. The percentages of transfected cells were analyzed 4 h
post-treatment with a ﬁnal concentration of 25 nM small RNA molecules (n) or 24 h with 50 nM (†). Grey colored: transfection
conditions as described in Ref. [1] and Fig. 4C.
% transfected cells siRNAn Pre-miRn Anti-miRn Anti-miR†
Psoriasis-induced KCs
HiPerfect 99.9 49.3 5.0
SEC 99.9 41.7 40.8
DDC642 99.9 46.8 12.0
Normal KCs
HiPerfect 99.9 20.7 37.2 29.2
SEC 99.9 16.6 63.0 94.2
DDC642 99.9 69.1 73.2 96.0
Melanocytes
HiPerfect 99.9 30.9 8.14
SEC 99.9 49.3 61.3
DDC642 99.9 46.6 25.5
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Fig. 3. MyoVa protein expression after pre-miR-145 transfection of melanocytes. (A) Representative blot of untreated and
treated cells. Lane 1: untreated; lane 2 and 5: empty vehicle; lane 3 and 6: pre-miR negative control #2; lane 4 and 7: pre-miR-
145. (B) Quantitative analysis of the gels. Samples were compared to untreated control and α-tubulin was used as loading
control. Error bars represent the mean7SD (n¼3). P-valueso0.05* compared to untreated control, † compared to HiPerfect.
E. Desmet et al. / Data in Brief 7 (2016) 1204–1210 1207and the complex stability (Fig. 1). Dilution series of ‘naked’ molecules were included to semi-quantify
(Image J software) the amount of unbound or repelled molecules (n¼3). Semi-quantitative data were
presented in Ref. [1].
2.3. Morphological visualization
Cryogenic transmission electron microscopy (Cryo-TEM) was performed as described in Ref. [3].
Brieﬂy, samples were placed on holey carbon-coated grids (Quantifoil 3.1/1), blotted and vitriﬁed
using a Vitrobot (FEI, Eindhoven, The Netherlands). Grids were observed in a FEI Tecnai 20 or a Philips
CM120 electron microscope operating at 200 and 120 keV using a Gatan model 626 cryo-stage.
Images were recorded on a slow-scan CCD camera under low-dose conditions (Fig. 2).
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Fig. 4. Cytotoxicity and stability assessment. (A) Cell viability of melanocytes (MC) and keratinocytes (KC) with increasing
amounts of liposomes for 4 h. (B, C) Physicochemical and biological activity of lipoplexes during storage. The expression level of
hBD-2 is relative to that of cells transfected with scrambled siRNA (100%). Data is shown as mean7SD (nZ3). P-valueso0.05*
compared to 5 mg mL1 (A) or day 0 condition (B, C).
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Flow cytometry was used to determine the percentage of transfected cells after treatment
(Table 1). Brieﬂy, cells seeded in P60 dishes were treated with LPXs containing ﬂuorescently labeled
E. Desmet et al. / Data in Brief 7 (2016) 1204–1210 1209pre-miR, siRNA, or anti-miR, as described previously [1]. 48 h after LPX application, cells were washed
with PBS and trypsinized. Following centrifugation (10 min, 1200 rpm), pellets were resuspended in
PBS and placed on ice until ﬂow analysis. Fluorescence was analyzed using a BD LSRFortessa (BD
Biosciences, Erembodegem, Belgium). A minimum of 10,000 cells was analyzed in each measurement.
FlowJo 9.7.6. software was used for analysis (Ashland, Oregon).
The silencing efﬁcacy of pre-miR-145-loaded liposomes in melanocytes was assessed by analyzing
the protein expression of myosin Va (MyoVa), a direct target of miR-145 [4], by means of Western
Blot. Forty-eight hours post-transfection, cultured melanocytes were lysed in RIPA buffer containing a
protease inhibitor cocktail (Sigma-Aldrich, Diegem, Belgium). Protein concentration was determined
using DC protein assay (Bio-Rad, Eke, Belgium) and Ultrospec 2100 pro UV/Visible spectrophotometer
(GE Healthcare, Buckinghamshire, UK). Solubilization of total cellular extracts and immunoblotting
was performed as described previously [5]. The primary antibody (anti-MyoVa exon F; Eurogentec,
Liège, Belgium (1:10,000)) was incubated overnight at 4 °C. Scanned protein bands (ChemiDoc-It
Imager, UVP, California, USA) were quantiﬁed with Image J software Fig. 3.
2.5. Cytotoxicity proﬁle of the liposomes
Cytotoxicity of the empty DDC642 liposomes was evaluated in cultured melanocytes (MC) and
keratinocytes (KC) as described previously [2]. Quantiﬁcation of the metabolic activity was carried out
on a FLUOstar OPTIMA (BMG Labtech, Temse, Belgium). Cell viability was calculated as the percentage
of luminescence compared to that of untreated cells (100%) (Fig. 4A).
2.6. Physicochemical and biological stability
Storage stability of the DDC642 lipoplexes was assessed as described earlier [2], and compared to
that of the SECoplexes. Particle size was measured every 10th day during a period of 30 days using
Zetasizer Nano series (Malvern, Worcestershire, UK) (Fig. 4B). In parallel, the biological stability was
assessed in vitro in the psoriasis-induced keratinocyte model using liposomes containing siRNA
directed against the DEFB4 gene [1,6]. The relative expression levels of hBD-2 in the transfected
keratinocytes was obtained by RT-qPCR (performed as previously described [1]) (Fig. 4C).
2.7. In vitro Franz diffusion cell permeation study
The penetration of Cy5-labeled DEFB4 siRNA lipoplexes through human skin was determined using
a static Franz diffusion cell set-up with a 5 mL receptor compartment and an available diffusion area
of 0.64 cm2 (Logan Instruments Corp., Somerset, New Jersey). Human skin from the abdominal and
back regionwas collected from three healthy female patients (3673 years old, mean7SEM) who had
undergone cosmetic reduction surgery, with informed consent, approval from the ethical committee
and conﬁdentiality procedures in place (University Hospital, Ghent, Belgium). Skin preparation was
done according to the internationally accepted guidelines [7] and as described previously [8]. Beside
intact split-thickness skin samples (experimentally obtained thickness: 37979 mm (mean7SEM)),
damaged, tape-stripped skin (20 times with Scotch magic tape, 3M) was included to evaluate the use
of a pre-treatment process but also for clinical purposes, e.g. an impaired skin barrier. Skin integrity
analysis showed overall impedance values of 16.771.5 kΩ and 54.874.1 kΩ (mean7SEM) for
respectively stripped and intact skin pieces, indicating signiﬁcant skin damage by tape-stripping (P-
valueo0.05). Skin samples, epidermis facing upwards, were sandwiched between the donor and
acceptor chambers, and the receptor ﬂuid (0.01 M PBS, pH 7.4) was continuously stirred (600 rpm).
Dose solutions (500 mL) from SEC and DDC642 lipoplexes were prepared with a ﬁnal concentration of
1000 nM Cy5-siRNA and topically applied to the skin surface. The donor chamber was covered with
paraﬁlm and the temperature of the receptor compartment was kept at 3271 °C. Samples (200 mL)
were drawn at regular time intervals (up to 6 h) from the sampling port and replaced immediately.
Samples were stored at 80 °C prior to analysis using the EnVision Multilabel Plate Reader (Perkin
Elmer, Zaventem, Belgium). A determination limit of 50 pM was established. The experiments were
E. Desmet et al. / Data in Brief 7 (2016) 1204–12101210replicated using 3 different skin donors, for both pre-treated skin (n¼6) as well as intact skin (n¼6).
Data was presented in Ref. [1].
2.8. Statistical analysis
Statistical analysis of differences between 2 conditions was performed as described elsewhere,
with a 0.05 level of probability (P-valueo0.05) as level of signiﬁcance [1].Acknowledgments
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